Applied DNA Sciences (APDN) Reaches $1.40 Yearly Low; 6 Bullish Analysts Covering GasLog Ltd (GLOG)

May 22, 2017 - By Ellis Scott

The stock of Applied DNA Sciences Inc (NASDAQ:APDN) hit a new 52-week low and has $1.36 target or 3.00% below today’s $1.40 share price. The 6 months bearish chart indicates high risk for the $33.32M company. The 1-year low was reported on May, 22 by Barchart.com. If the $1.36 price target is reached, the company will be worth $999,600 less. It is 0.00% or $0 reaching $1.4 per share. It is down 49.09% since May 22, 2016 and is downtrending. It has underperformed by 65.79% the S&P500.

Among 9 analysts covering GasLog (NYSE:GLOG), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. GasLog had 20 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of GasLog Ltd (NYSE:GLOG) has “Buy” rating given on Friday, September 4 by ABN Amro. The firm earned “Outperform” rating on Wednesday, January 25 by Wells Fargo. JP Morgan downgraded GasLog Ltd (NYSE:GLOG) rating on Wednesday, March 16. JP Morgan has “Underweight” rating and $9 target. As per Thursday, December 17, the company rating was downgraded by Wells Fargo. The stock of GasLog Ltd (NYSE:GLOG) earned “Neutral” rating by Citigroup on Monday, February 22. The firm has “Buy” rating by Citigroup given on Friday, August 7. The company was maintained on Friday, February 26 by Cowen & Co. The stock of GasLog Ltd (NYSE:GLOG) has “Neutral” rating given on Wednesday, November 23 by Seaport Global Securities. The rating was initiated by Credit Suisse on Wednesday, April 26 with “”. On Tuesday, February 21 the stock rating was upgraded by JP Morgan to “Neutral”. See GasLog Ltd (NYSE:GLOG) latest ratings:

26/04/2017 Broker: Credit Suisse Rating: New Target: $21.00 Initiate
21/02/2017 Broker: JP Morgan Old Rating: Underweight New Rating: Neutral Upgrade
21/02/2017 Broker: Seaport Global Securities Old Rating: Neutral New Rating: Buy Old Target: $18 New Target: $23 Upgrade
15/02/2017 Broker: Citigroup Old Rating: Neutral New Rating: Buy Upgrade
25/01/2017 Broker: Wells Fargo Old Rating: Market Perform New Rating: Outperform Upgrade
23/11/2016 Broker: Seaport Global Securities Rating: Neutral New Target: $18 Initiate

Applied DNA Sciences, Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The company has market cap of $33.32 million. The Firm is also engaged in the large-scale production of specific deoxyribonucleic acid sequences using the polymerase chain reaction (PCR). It currently has negative earnings. The Company’s principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon.

Investors sentiment increased to 1.33 in 2016 Q4. Its up 0.33, from 1 in 2016Q3. It improved, as 4 investors sold Applied DNA Sciences Inc shares while 5 reduced holdings. 6 funds opened positions while 6 raised stakes. 3.85 million shares or 126.09% more from 1.70 million shares in 2016Q3 were reported. Blackrock Investment Mgmt Lc reported 0% in Applied DNA Sciences Inc (NASDAQ:APDN). Chase Invest Counsel accumulated 0.07% or 77,563 shares. Goldman Sachs Grp holds 0% of its portfolio in Applied DNA Sciences Inc (NASDAQ:APDN) for 13,678 shares. Tower Limited Liability (Trc) owns 5,531 shares for 0% of their portfolio. Geneva Advsr Lc accumulated 0% or 50,000 shares. Blackrock Institutional Na holds 152,634 shares. Texas-based Next Finance Grp Inc has invested 0% in Applied DNA Sciences Inc (NASDAQ:APDN). Commonwealth Equity invested in 17,968 shares. Gluskin Sheff & Assocs Inc owns 20,000 shares for 0% of their portfolio. Wells Fargo And Co Mn holds 6,935 shares or 0% of its portfolio. Anson Funds L P stated it has 0.08% in Applied DNA Sciences Inc (NASDAQ:APDN). Oppenheimer & Com reported 13,527 shares. 6,764 were accumulated by Blackrock Advisors Ltd Liability Co. Dumont And Blake Investment Lc reported 20,921 shares stake. Benchmark Capital Advsrs invested in 0.21% or 138,000 shares.

It is down 20.14% since May 22, 2016 and is uptrending. It has outperformed by 3.44% the S&P500.